We are live on ! Find out more
AUPH icon

Aurinia Pharmaceuticals
AUPH

189 hedge funds and large institutions have $421M invested in Aurinia Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 57 increasing their positions, 54 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

87% more call options, than puts

Call options by funds: $23.8M | Put options by funds: $12.7M

3.61% more ownership

Funds ownership: 35.8% → 39.41% (+3.6%)

6% more repeat investments, than reductions

Existing positions increased: 57 | Existing positions reduced: 54

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

5% less funds holding

Funds holding: 199 → 189 (-10)

18% less capital invested

Capital invested by funds: $510M → $421M (-$89.8M)

26% less first-time investments, than exits

New positions opened: 23 | Existing positions closed: 31

Holders
189
Holders Change
-10
Holders Change %
-5.03%
% of All Funds
3.26%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
23
Increased
57
Reduced
54
Closed
31
Calls
$23.8M
Puts
$12.7M
Net Calls
+$11.1M
Net Calls Change
-$404K

Top Buyers

1
DTC
Deep Track Capital
Connecticut
+$49.1M
2
Citadel Advisors
Citadel Advisors
Florida
+$16.3M
3
AC
Armistice Capital
New York
+$6.27M
4
IBT
International Biotechnology Trust
United Kingdom
+$4.91M
5
Two Sigma Investments
Two Sigma Investments
New York
+$4.54M

Top Sellers

1
Morgan Stanley
Morgan Stanley
New York
-$12.3M
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$8.14M
3
N
Natixis
France
-$7.55M
4
KAS
Kestra Advisory Services
Texas
-$5.87M
5
Barclays
Barclays
United Kingdom
-$3.33M
Name Holding Trade Value Shares
Change 		Change in
Stake
NFG
26
Norris Financial Group
South Carolina
$3.16M +$69.5K +8,029 +2%
Bank of New York Mellon
27
Bank of New York Mellon
New York
$3.06M +$310K +35,854 +10%
Jane Street
28
Jane Street
New York
$3.05M -$1.58M -183,105 -31%
Wells Fargo
29
Wells Fargo
California
$2.63M -$255K -29,460 -8%
Hudson Bay Capital Management
30
Hudson Bay Capital Management
Connecticut
$2.37M +$1.2M +138,200 +78%
HWAM
31
Hennion & Walsh Asset Management
New Jersey
$2.27M +$31.5K +3,637 +1%
Walleye Capital
32
Walleye Capital
New York
$2.23M +$2.57M +296,708 New
Charles Schwab
33
Charles Schwab
California
$2.23M +$866 +100 +0%
KPWS
34
Kestra Private Wealth Services
Texas
$2.16M -$2.55M -294,208 -51%
Swiss National Bank
35
Swiss National Bank
Switzerland
$2.15M +$217K +25,100 +10%
GF
36
Gabelli Funds
New York
$2.11M -$952K -110,000 -28%
Bank of America
37
Bank of America
North Carolina
$1.95M +$1.14M +132,083 +104%
Parallax Volatility Advisers
38
Parallax Volatility Advisers
California
$1.85M +$399K +46,082 +23%
HP
39
HealthInvest Partners
Sweden
$1.73M – – –
TCM
40
Tang Capital Management
California
$1.5M +$1.73M +200,000 New
Capital Fund Management (CFM)
41
Capital Fund Management (CFM)
France
$1.43M +$419K +48,360 +34%
ASN
42
Advisory Services Network
Georgia
$1.42M -$556K -64,217 -25%
CSS
43
Cubist Systematic Strategies
Connecticut
$1.4M +$1.61M +185,979 New
GGHC
44
Gilder Gagnon Howe & Co
New York
$1.35M -$7.58K -876 -0.5%
LSA
45
Leonteq Securities AG
Switzerland
$1.3M -$36.4K -4,200 -2%
RhumbLine Advisers
46
RhumbLine Advisers
Massachusetts
$1.23M +$104K +12,005 +8%
AA
47
AlphaCentric Advisors
Puerto Rico
$1.2M +$1.38M +159,500 New
California State Teachers Retirement System (CalSTRS)
48
California State Teachers Retirement System (CalSTRS)
California
$1.18M +$45.9K +5,306 +4%
CF
49
Cantor Fitzgerald
New York
$1.14M -$135K -15,580 -9%
CS
50
Credit Suisse
Switzerland
$1.06M +$401K +46,328 +49%
1
2
3 4 5

AUPH Hedge Fund Activity: Q3 2022 in Review

189 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Aurinia Pharmaceuticals (AUPH) for Q3 2022, worth a combined $421M — down 18% from $510M a quarter earlier.

Sellers outnumbered buyers: 31 funds closed out of AUPH and 23 opened new positions — a net loss of 8 holders — while 54 trimmed existing stakes and 57 added.

The largest buyer was Deep Track Capital, opening a new position worth an estimated $49.1M. The largest seller was Morgan Stanley, cutting an estimated $12.3M.

  • 189 institutional investors held Aurinia Pharmaceuticals (AUPH) as of Q3 2022, down from 199 in Q2 2022.
  • Funds reported $421M of Aurinia Pharmaceuticals stock for Q3 2022, down 18% quarter-over-quarter.
  • 23 funds opened new Aurinia Pharmaceuticals positions in Q3 2022 and 31 closed out, a net change of -8 holders.
  • The largest Aurinia Pharmaceuticals buyer in Q3 2022 was Deep Track Capital, an estimated $49.1M added.
  • The largest Aurinia Pharmaceuticals seller in Q3 2022 was Morgan Stanley, an estimated $12.3M sold.

Based on aggregated 13F filings for Q3 2022.